BERMAN ROBERT ANDREW (Chief Executive Officer) purchased 407.6% of their position (3K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market purchase worth $16.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/19/2021ACC: 0001493152-21-012298
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+3K
Net shares
Net buyer
$16.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock, $0.00001 par value
Direct
Shares
+3K
Price / share
$5.47
Trade value
$16.41K
% of position
407.6%
5/18/2021
736.00→3.74K
Total
Net shares
+3K
Net value
$16.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 par value Direct | 5/18/2021 | P · Purchase | +3K | $5.47 | $16.41K | 407.6% | 736.00 | 3.74K |
| Total | +3K | $16.41K | ||||||
Derivative Transactions0
No derivative transactions reported